| 英文别名 |
p38 MAPK-IN-1;BCP24818;BDBM50357886;4-(2,4-difluoro-phenyl)-8-o-tolyl-1,7-naphthyridine-7-oxide;p38alpha-IN-4;p38alpha-IN-4;1006378-90-0;1006378-90-0;4-(2,4-difluorophenyl)-8-(2-methylphenyl)-1,7-naphthyridin-7-ium-7-olate;4-(2,4-difluorophenyl)-8-(2-methylphenyl)-1,7-naphthyridin-7-ium-7-olate;4-(2,4-difluorophenyl)-8-(o-tolyl)-1,7-naphthyridine 7-oxide;4-(2,4-difluorophenyl)-8-(o-tolyl)-1,7-naphthyridine 7-oxide;MS-25390;MS-25390;4-(2,4-Difluorophenyl)-8-(2-methylphenyl)-1,7-naphthyridine-7-oxide;4-(2,4-Difluorophenyl)-8-(2-methylphenyl)-1,7-naphthyridine-7-oxide;HY-12839;HY-12839;p38alpha-IN-4; p38alpha IN 4; p38alphaIN4; p38alpha inhibitor 4; p38alpha-inhibitor-4; p38 MAP Kinase Inhibitor XI;p38alpha-IN-4; p38alpha IN 4; p38alphaIN4; p38alpha inhibitor 4; p38alpha-inhibitor-4; p38 MAP Kinase Inhibitor XI;AKOS030260401;AKOS030260401;F85179;F85179;SCHEMBL2077831;SCHEMBL2077831;DA-66432;DA-66432;CHEMBL1916344;CHEMBL1916344;4-(2,4-difluorophenyl)-8-(2-methylphenyl)-7-oxido-1,7-naphthyridin-7-ium;4-(2,4-difluorophenyl)-8-(2-methylphenyl)-7-oxido-1,7-naphthyridin-7-ium |
微信公众号
客服
